Medifast (MED) Tops Q1 EPS by 15c; Offers FY18 Outlook

Medifast (NYSE: MED) reported Q1 EPS of $1.01, $0.15 better than the analyst estimate of $0.86. Revenue for the quarter came in at $98.6 million versus the consensus estimate of $89.93 million.

Outlook

The Company expects second quarter revenue to be in the range of $99.0 million to $102.0 million and earnings per diluted share to be in the range of $0.94 to $0.97. The Company is raising its guidance for the full year 2018, expecting revenue of $385 million to $395 million and earnings per diluted share of $3.55 to $3.65. This compares to the Company\'s previous annual guidance for revenue of $350 million to $360 million and earnings per diluted share of $3.15 to $3.25. The full year 2018 earnings guidance assumes a 21% to 22% effective tax rate.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Schlumberger (SLB) earnings in-line, revenue beats expectations
• Oilfield firm SLB's profit rises on international drilling demand
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance